Convergence of Diagnostics and Population Health | February 28, 2022
The COVID-19 pandemic has illustrated how today’s health care environment and current delivery models are ill-equipped to adequately address community health and public safety. This Project Santa Fe Foundation thought leadership publication proposes an advanced role for the clinical laboratory as a key partner for population health management, health outcomes, and public safety.
Please flip through the below document. If you would like to download a printable version, fill out the form at the bottom of this page.
AUTHORS:
Khosrow R. Shotorbani, MBA, MT (ASCP)
President/Executive Director Project Santa Fe Foundation
Founder, CEO Lab 2.0 Strategic Services, LLC
Salt Lake City, UT
Khosrow.shotorboni@me.com
Kathleen M. Swanson, MS, RPh
Manager, CL 2.0 Demonstration Projects
Faculty, Project Santa Fe Foundation
Albuquerque, NM
Kathleen.swanson1@outlook.com
Mark K Fung, MD PhD
Board of Directors, Project Santa Fe Foundation
Vice Chair for Research, Pathology and Laboratory Medicine
University of Vermont Medical Center
Burlington, VT 05401
Mark.Fung@uvmhealth.org
Jill Warrington, MD, PhD
Director for Population Health, Pathology and Laboratory Medicine
Larner College of Medicine, University of Vermont
Chief Scientific Officer, Averhealth
Laboratory Director, Vermont Department of Health Laboratory
Burlington, VT
jwarrington@averhealth.com
Beth Bailey
Faculty, Project Santa Fe Foundation
Director, Strategic Development and Communications
TriCore Reference Laboratories
Albuquerque, NM
beth.bailey@tricore.org
Michael J Crossey, MD, PhD
Board of Directors, Project Santa Fe Foundation
Chief Medical Officer
TriCore Reference Laboratories
Albuquerque, NM
michael.crossey@tricore.org